Haemophilia

Overview of Haemophilia A and B.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)

Last reviewed: 21 October 2025

Haematology

Clinical Guidelines

NICE guideline [TA989]: Etranacogene dezaparvovec for treating moderately severe or severe haemophilia B

UKHCDO Guidelines

Acquired haemophilia A: Italian Consensus Recommendations on Diagnosis, Management and Care

ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease

Clinical Commissioning Policy: The use of Rituximab as a second line agent for the eradication of inhibitors in patients with acquired haemophilia

Guidelines for the management of haemophilia in Australia

ISTH Clinical Practice Guideline for Treatment of Congenital Haemophilia

MASAC Guidelines for Pregnancy and Perinatal Management of Women with Inherited Bleeding Disorders and Carriers of Hemophilia A or B (MASAC Document 265)

National Hemophilia Foundation (NHF)-McMaster University Guideline on Care Models for Haemophilia Management

Society of Interventional Radiology Consensus Guidelines for the Management of Patients with Hemophilia and von Willebrand Disease Undergoing Interventional Procedures

UKHCDO Guidance for implementation of haemophilia gene therapy into routine clinical practice for adults

UKHCDO Guideline: Diagnosis and management of acquired coagulation inhibitors

WFH Guidelines for the Management of Hemophilia, 3rd edition